Clinicians & Providers

• Antenatal Identification of Major Depressive Disorder: a Cohort Study

Other Research & Data

• Antenatal Identification of Major Depressive Disorder: a Cohort Study

Press Releases

October 18 2011 20111018

Birth Defects May Be Linked to High Blood Pressure, Not Use of ACE Inhibitors in Early Pregnancy

Other News & Events

• Accuracy of ultrasound for ectopic pregnancy in the emergency department is not helped by measuring a key pregnancy hormone
• Acupuncture helps with depression during pregnancy
• Antenatal Identification of Major Depressive Disorder: a Cohort Study
• Bariatric surgery before pregnancy reduces the risk of gestational diabetes in obese women
• Birth defects may be linked to high blood pressure, not use of ACE inhibitors in early pregnancy
• Certain women are at greater risk for mental health problems during pregnancy
• Giving birth to a small gestational age infant increases likelihood of later maternal ischemic heart disease
• Home visits help pregnant, Medicaid-insured women alleviate depressive symptoms
• More research is needed on outcomes after maternal-fetal surgery
• Pelvic ultrasound imaging by emergency physicians is highly effective in ruling out ectopic pregnancy
• Perceived lower social standing linked to unplanned pregnancies
• Prenatal screening for Group B streptococci often fails to live up to current screening and treatment guidelines
• Progestogens effective for preventing preterm births in single pregnancies
• Providers miss opportunities to prevent depression in and discuss birth control with women with unplanned pregnancies
• Recent trends in hospital use by children and youths are a mixed bag—lower for teen pregnancies, much higher for skin infections
• Uncertainty surrounds use of terbutaline to prevent preterm birth
• Using a terbutaline pump to prevent preterm birth may be beneficial, but evidence suggests caution
• Vaginal births after cesarean are safe for most women
• While treatments for miscarriage are safe, providers do not always offer them all to their patients
• Women want clinicians to talk about the risk medications pose to an unborn child